Renaissance Technologies’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-599,151
| Closed | -$31.4M | – | 3887 |
|
|
2020
Q3 | $31.4M | Buy |
599,151
+182,900
| +44% | +$7.57M | 0.03% | 538 |
|
|
2020
Q2 | $13.8M | Buy |
416,251
+359,237
| +630% | +$11.4M | 0.01% | 1031 |
|
|
2020
Q1 | $1.55M | Sell |
57,014
-707,834
| -93% | -$19.7M | ﹤0.01% | 2193 |
|
|
2019
Q4 | $15.1M | Sell |
764,848
-532,638
| -41% | -$8.52M | 0.01% | 1173 |
|
|
2019
Q3 | $16.8M | Sell |
1,297,486
-319,804
| -20% | -$3.86M | 0.01% | 1061 |
|
|
2019
Q2 | $20.1M | Sell |
1,617,290
-93,800
| -5% | -$1.25M | 0.02% | 961 |
|
|
2019
Q1 | $24.9M | Buy |
1,711,090
+227,500
| +15% | +$2.91M | 0.02% | 861 |
|
|
2018
Q4 | $16.4M | Buy |
1,483,590
+200,390
| +16% | +$2.79M | 0.02% | 1010 |
|
|
2018
Q3 | $33.7M | Sell |
1,283,200
-95,300
| -7% | -$2.58M | 0.03% | 629 |
|
|
2018
Q2 | $28.2M | Sell |
1,378,500
-44,900
| -3% | -$963K | 0.03% | 725 |
|
|
2018
Q1 | $25.8M | Sell |
1,423,400
-159,600
| -10% | -$2.66M | 0.03% | 785 |
|
|
2017
Q4 | $22.1M | Buy |
1,583,000
+134,500
| +9% | +$1.82M | 0.02% | 877 |
|
|
2017
Q3 | $26.8M | Buy |
1,448,500
+651,100
| +82% | +$10.9M | 0.03% | 726 |
|
|
2017
Q2 | $13.5M | Buy |
797,400
+519,000
| +186% | +$7.9M | 0.02% | 1081 |
|
|
2017
Q1 | $3.72M | Sell |
278,400
-118,700
| -30% | -$1.86M | 0.01% | 1882 |
|
|
2016
Q4 | $5.98M | Buy |
397,100
+104,300
| +36% | +$1.38M | 0.01% | 1546 |
|
|
2016
Q3 | $3.42M | Sell |
292,800
-71,870
| -20% | -$845K | 0.01% | 1856 |
|
|
2016
Q2 | $3.94M | Sell |
364,670
-664,381
| -65% | -$6.85M | 0.01% | 1767 |
|
|
2016
Q1 | $9.51M | Buy |
1,029,051
+478,465
| +87% | +$5.15M | 0.02% | 1172 |
|
|
2015
Q4 | $8.17M | Buy |
550,586
+112,220
| +26% | +$1.88M | 0.02% | 1132 |
|
|
2015
Q3 | $7.19M | Sell |
438,366
-28,485
| -6% | -$583K | 0.02% | 1141 |
|
|
2015
Q2 | $10.6M | Buy |
466,851
+232,400
| +99% | +$4.63M | 0.02% | 909 |
|
|
2015
Q1 | $3.56M | Buy |
234,451
+4,100
| +2% | +$53.3K | 0.01% | 1575 |
|
|
2014
Q4 | $2.77M | Sell |
230,351
-136,000
| -37% | -$1.55M | 0.01% | 1629 |
|
|
2014
Q3 | $4.15M | Sell |
366,351
-173,900
| -32% | -$1.98M | 0.01% | 1259 |
|
|
2014
Q2 | $6.53M | Buy |
540,251
+115,117
| +27% | +$1.36M | 0.02% | 1081 |
|
|
2014
Q1 | $4.95M | Buy |
+425,134
| New | +$7.2M | 0.01% | 1253 |
|
|
2013
Q3 | – | Sell |
-59,751
| Closed | -$900K | – | 3006 |
|
|
2013
Q2 | $900K | Buy |
+59,751
| New | +$789K | ﹤0.01% | 1979 |
|
Renaissance Technologies's MNTA Position: Q4 2020 in Review
Renaissance Technologies sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 599,151 shares — an estimated $31.4M sold.
Renaissance Technologies first reported a position in MNTA in Q2 2013 and held it in 28 quarters. The position peaked at $33.7M in Q3 2018. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Renaissance Technologies reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Renaissance Technologies sold 599,151 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $31.4M.
- Renaissance Technologies first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 28 quarters.
- Renaissance Technologies's Momenta Pharmaceuticals, Inc. position peaked at $33.7M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Renaissance Technologies's 13F filing for Q4 2020, filed 10 Feb 2021.